Suchen Sie nach Informationen zu Hauptsitz Von Abeona Therapeutics? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.
https://www.abeonatherapeutics.com/
ABO-102. In Phase 1/2 development. One-time, AAV-based gene therapy for patients with Sanfilippo syndrome type A (MPS IIIA). Learn More.
https://www.dnb.com/business-directory/company-profiles.abeona_therapeutics_inc.652c07a46de97b2b1c5ba95c3cc9b105.html
Company Description: Abeona Therapeutics (formerly PlasmaTech Pharmaceuticals) is developing treatments to tap into the cancer therapy market. The company makes pharmaceutical products based on nanopolymer chemistry and other drug delivery technologies. Its FDA-approved MuGard is a prescription oral rinse for the treatment of mucositis, or mouth …
https://craft.co/abeona-therapeutics/locations
3333 Lee Pkwy #600. HQ. United States. Cleveland. 6555 Carnegie Ave 4th floor. United States. New York. 1330 6th Ave 33rd Floor. Spain.
https://www.datanyze.com/companies/abeona-therapeutics/358383541
Abeona Therapeutics Profile and History. Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing gene and cell therapies for serious diseases. Abeona's clinical programs include: EB-101, its investigational autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa in Phase 3 development; novel investigational AAV …
https://investors.abeonatherapeutics.com/company-information
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing cell and gene therapies for serious diseases. Abeona’s lead clinical program is EB-101, its investigational autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa in Phase 3 development. The Company’s development portfolio also features AAV-based gene therapies …
https://craft.co/abeona-therapeutics
Overview Suggest Edit. Abeona Therapeutics is a clinical stage company developing gene therapy and plasma-based therapies for severe and life-threatening rare genetic diseases. The Company’s lead programs include ABO-102 (AAV-SGSH), an adeno-associated virus based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and EB-101 (gene-corrected skin …
https://investors.abeonatherapeutics.com/profile
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing cell and gene therapies for serious diseases. Abeona’s lead clinical program is EB-101, its investigational autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa in Phase 3 development. The Company’s development portfolio also features AAV-based gene therapies …
https://finance.yahoo.com/quote/ABEO/profile
Abeona Therapeutics Inc. 1330 Avenue of the Americas 33rd Floor New York, NY 10019 United States 646 813 4701 https://www.abeonatherapeutics.com Sector(s) : Healthcare Industry : Biotechnology ...
https://www.bloomberg.com/profile/company/0921853D:US
Company profile page for Abeona Therapeutics LLC including stock price, company news, press releases, executives, board members, and contact information
https://investchronicle.com/2022/07/11/abeona-therapeutics-inc-abeo-dont-ignore-this-blaring-warning-signal/
By Sarah Baker. July 11, 2022. Abeona Therapeutics Inc. (ABEO) is priced at $5.49 after the most recent trading session. At the very opening of the session, the stock price was $4.44 and reached a high price of $5.63, prior to closing the session it reached the value of $4.52.
Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Hauptsitz Von Abeona Therapeutics gefunden haben.
